AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 69 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $29,000 | -60.8% | 3,727 | -60.5% | 0.00% | – |
| Q4 2020 | $74,000 | +124.2% | 9,432 | +119.2% | 0.00% | – |
| Q3 2020 | $33,000 | -31.2% | 4,303 | -20.3% | 0.00% | – |
| Q2 2020 | $48,000 | +585.7% | 5,399 | +219.1% | 0.00% | – |
| Q1 2020 | $7,000 | -81.6% | 1,692 | -66.3% | 0.00% | – |
| Q4 2019 | $38,000 | +22.6% | 5,014 | +25.9% | 0.00% | – |
| Q3 2019 | $31,000 | -34.0% | 3,984 | -41.0% | 0.00% | – |
| Q2 2019 | $47,000 | +88.0% | 6,749 | +116.5% | 0.00% | – |
| Q1 2019 | $25,000 | 0.0% | 3,118 | -5.5% | 0.00% | – |
| Q4 2018 | $25,000 | -50.0% | 3,298 | -36.8% | 0.00% | – |
| Q3 2018 | $50,000 | +51.5% | 5,219 | +64.4% | 0.00% | – |
| Q2 2018 | $33,000 | -44.1% | 3,174 | -46.4% | 0.00% | – |
| Q1 2018 | $59,000 | +268.8% | 5,923 | +97.4% | 0.00% | – |
| Q4 2017 | $16,000 | – | 3,000 | +22976.9% | 0.00% | – |
| Q3 2017 | $0 | – | 13 | -23.5% | 0.00% | – |
| Q2 2017 | $0 | – | 17 | -15.0% | 0.00% | – |
| Q4 2016 | $0 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |